Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on Camtek, Raises Price Target to $40

Needham Maintains Buy on Camtek, Raises Price Target to $40

Needham analyst Charles Shi maintains Camtek (NASDAQ:CAMT) with a Buy and raises the price target from $36 to $40.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Needham analyst Charles Shi maintains Camtek (NASDAQ:CAMT) with a Buy and raises the price target from $36 to $40.

Alphabet Analysts Raise Their Forecasts After Upbeat Q2 Earnings

By Lisa Levin

July 26, 7:18 AM

Alphabet Inc. (NASDAQ: GOOGL) reported better-than-expected second-quarter results.

GOOGL

Analyst Ratings

Wolfe Research Maintains Outperform Rating for Amazon.com: Here’s What You Need To Know

By Benzinga Insights

April 28, 1:00 PM

Wolfe Research has decided to maintain its Outperform rating of Amazon.com (NASDAQ:AMZN) and raise its price target from…

AMZN

Moderna Teams Up With Chinese Biotech To Assess Cell-Based Therapy And Cancer Vaccine Combo

By Vandana Singh

August 21, 11:20 AM

A Chinese biotech, CARsgen Therapeutics and Moderna Inc (NASDAQ: MRNA) have collaborated

MRK

GM Recalls Nearly 7,000 Chevrolet Bolt EVs After Halting Production

By Anan Ashraf

December 22, 7:04 AM

If these vehicles are involved in a crash and their seat belt pretensioners are deployed, the exhaust of the pretensioner may ignite carpet fibers, thereby causing a fire.

Needham Maintains Buy on Camtek, Raises Price Target to $40

Related Posts

Alphabet Analysts Raise Their Forecasts After Upbeat Q2 Earnings

Wolfe Research Maintains Outperform Rating for Amazon.com: Here’s What You Need To Know

Moderna Teams Up With Chinese Biotech To Assess Cell-Based Therapy And Cancer Vaccine Combo

GM Recalls Nearly 7,000 Chevrolet Bolt EVs After Halting Production